CJC-1295 + Ipamorelin
Combination blend pairing a long-acting GHRH analog with a selective ghrelin-receptor secretagogue.
This product is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. By purchasing, you confirm you are a qualified researcher or institution acquiring this product solely for in-vitro laboratory research. See our Research Disclaimer for full terms.
Description
This blend combines CJC-1295 (a GHRH analog modified with Drug Affinity Complex technology for extended plasma half-life via albumin binding) with Ipamorelin (a selective ghrelin receptor agonist). Research on the combination centers on the two compounds' complementary, non-overlapping mechanisms: CJC-1295 sustains elevated baseline GHRH-receptor signaling, while Ipamorelin triggers a discrete, selective GH pulse. Studies of GHRH-analog/secretagogue co-administration have reported synergistic increases in GH pulse amplitude relative to either compound alone. Supplied for in-vitro laboratory research only — not for human or veterinary use.